Durbin, Kennedy Applaud DEA for Lowering Opioid Quotas for Fourth Year in Row
September 12, 2019
September 12, 2019
WASHINGTON, Sept. 12 -- Sen. Richard J. Durbin, D-Illinois, issued the following news release:
U.S. Senators Dick Durbin (D-IL) and John Kennedy (R-LA) today praised the Drug Enforcement Administration's (DEA) proposal to reduce production quotas for nearly all Schedule II prescription opioids by an average of 32 percent for next year. The DEA is responsible for establishing annual quotas determining the exact amount of each opioid drug that is permitted to be produced in the U.S. e . . .
U.S. Senators Dick Durbin (D-IL) and John Kennedy (R-LA) today praised the Drug Enforcement Administration's (DEA) proposal to reduce production quotas for nearly all Schedule II prescription opioids by an average of 32 percent for next year. The DEA is responsible for establishing annual quotas determining the exact amount of each opioid drug that is permitted to be produced in the U.S. e . . .